SSRIs block SARS-CoV-2 protease in silico

In a molecular docking analysis, Tronco Pauletto et al. found that antidepressants such as fluoxetine, citalopram, and norfluoxetine likely interact with and disrupt SARS-CoV-2 main protease (Mpro, 3CLpro).